In vivo assessment of the cutaneous bioavailability of topically applied maxacalcitolIKEDA, Y; HIRATA, K; KANO, S et al.Methods and findings in experimental and clinical pharmacology. 2005, Vol 27, Num 5, pp 305-310, issn 0379-0355, 6 p.Article

Clinical effect of vitamin D₃ analogues is not inactivated by subsequent UV exposureADACHI, Yuka; UCHIDA, Naoko; MATSUO, Tomoo et al.Photodermatology photoimmunology & photomedicine. 2008, Vol 24, Num 1, pp 16-18, issn 0905-4383, 3 p.Article

Maxacalcitol therapy decreases circulating osteoprotegerin levels in dialysis patients with secondary hyperparathyroidismKAZAMA, J. J; OMORI, K; TAKAHASHI, N et al.Clinical nephrology. 2005, Vol 64, Num 1, pp 64-68, issn 0301-0430, 5 p.Article

Treatment of psoriasis vulgaris with narrow-band UVB and topical maxacalcitolTAKEKOSHI, Tomonori; ASAHINA, Akihiko; KOMINE, Mayumi et al.Acta dermato-venereologica. 2006, Vol 86, Num 4, pp 375-376, issn 0001-5555, 2 p.Article

Infantile Acropustulosis Treated Successfully With Topical MaxacalcitolKIMURA, Masaaki; HIGUCHI, Tetsuya; YOSHIDA, Masami et al.Acta dermato-venereologica. 2011, Vol 91, Num 3, pp 363-364, issn 0001-5555, 2 p.Article

Active vitamin D analogs, maxacalcitol and alfacalcidol, as maintenance therapy for mild secondary hyperparathyroidism in hemodialysis patients ― a randomized studyHONDA, Hirokazu; KOIWA, Fumihiko; KINO, Kyoko et al.International journal of clinical pharmacology and therapeutics. 2014, Vol 52, Num 5, pp 360-368, issn 0946-1965, 9 p.Article

A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidismADACHI, M; MIYOSHI, T; SHIRAISHI, N et al.Clinical nephrology. 2011, Vol 76, Num 4, pp 266-272, issn 0301-0430, 7 p.Article

Successful Treatment of Bowen's Disease with Topical MaxacalcitolKARASHIMA, Tadashi; HASHIKAWA, Keiko; ONO, Fumitake et al.Acta dermato-venereologica. 2012, Vol 92, Num 6, pp 660-661, issn 0001-5555, 2 p.Article

Recent developments in vitamin D analogsFOGH, Karsten; KRAGBALLE, Knud.Current pharmaceutical design. 2000, Vol 6, Num 9, pp 961-972, issn 1381-6128Article

Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D₃, maxacalcitol, on the proliferation of pancreatic cancer cell linesKAWA, Shigeyuki; YOSHIZAWA, Kaname; NIKAIDO, Toshio et al.Journal of steroid biochemistry and molecular biology. 2005, Vol 97, Num 1-2, pp 173-177, issn 0960-0760, 5 p.Conference Paper

Combination therapy using maxacalcitol and corticosteroid lotions preliminary to monotherapy with maxacalcitol lotion for scalp psoriasisOKUBO, Yukari; NATSUME, Shoko; USUI, Kae et al.Journal of dermatological treatment. 2014, Vol 25, Num 1, pp 34-37, issn 0954-6634, 4 p.Article

Comparison of the efficacy of calcipotriol and maxacalcitol in combination with narrow-band ultraviolet B therapy for the treatment of psoriasis vulgarisNOBORIO, Reiko; KOBAYASHI, Keiko; SHINTANI, Yoichi et al.Photodermatology photoimmunology & photomedicine. 2006, Vol 22, Num 5, pp 262-264, issn 0905-4383, 3 p.Article

Verrucous skin lesions on the feet in diabetic neuropathy successfully treated with topical maxacalcitolMURAO, Kazutoshi; OSHIMA, Mika; MIYAJIMA, Osamu et al.EJD. European journal of dermatology. 2012, Vol 22, Num 2, pp 274-275, issn 1167-1122, 2 p.Article

Topical maxacalcitol for the treatment of psoriasis vulgaris : a placebo-controlled, double-blind, dose-finding study with active comparatorBARKER, J. N. W. N; ASHTON, R. E; MARKS, R et al.British journal of dermatology (1951). 1999, Vol 141, Num 2, pp 274-278, issn 0007-0963Article

Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patientsYAMAMOTO, Hiroyasu; KATOH, Naohiko; TAKEYAMA, Hiroshi et al.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, pp iii50-iii52, issn 0931-0509, SUP3Conference Paper

Development of hungry bone syndrome after rapid lowering of PTH with intravenous maxacalcitol therapy in a patient with non-uremic secondary hyperparathyroidismKAZAMA, J. J; SUZUKI, K; YOKOSEKI, A et al.Clinical nephrology. 2003, Vol 60, Num 5, pp 369-371, issn 0301-0430, 3 p.Article

Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cellsSHIIZAKI, Kazuhiro; HAYAKAWA, Naohiko; IMAZEKI, Ikuo et al.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, Num 4, pp 1078-1086, issn 0931-0509, 9 p.Article

Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in ratsMATSUI, Isao; HAMANO, Takayuki; IMAI, Enyu et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 8, pp 2354-2361, issn 0931-0509, 8 p.Article

Prospective comparison of the effects of maxacalcitol and calcitriol in chronic hemodialysis patients with secondary hyperparathyroidism : a multicenter, randomized crossover studyMOCHIZUKI, T; NAGANUMA, S; TANAKA, Y et al.Clinical nephrology. 2007, Vol 67, Num 1, pp 12-19, issn 0301-0430, 8 p.Article

Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3INOUE, Kazunori; MATSUI, Isao; TSUBAKIHARA, Yoshiharu et al.Laboratory investigation. 2012, Vol 92, Num 12, pp 1686-1697, issn 0023-6837, 12 p.Article

Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium × phosphorus product in secondary hyperparathyroidismTANAKA, Motoko; ITOH, Kazuko; MATSUSHITA, Kazunori et al.The Nephron journals. 2006, Vol 102, Num 1, pp c1-c7, issn 1660-8151Article

A case of mosaic-type bullous congenital ichthyosiform erythroderma successfully treated with topical maxacalcitol, a vitamin D3 analogueUMEKOJI, A; FUKAI, K; ISHII, M et al.Clinical and experimental dermatology (Print). 2008, Vol 33, Num 4, pp 501-502, issn 0307-6938, 2 p.Article

Comedolytic effect of topically applied active vitamin D₃analogue on pseudocomedones in the rhino mouseHAYASHI, N; WATANABE, H; YASUKAWA, H et al.British journal of dermatology (1951). 2006, Vol 155, Num 5, pp 895-901, issn 0007-0963, 7 p.Article

Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trialHAYASHI, Matsuhiko; TSUCHIYA, Yoshitsugu; ITAYA, Yoshiaki et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 8, pp 2067-2073, issn 0931-0509, 7 p.Article

Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidismKAZAMA, Junichiro J; OMORI, Kentaro; HIGUCHI, Noboru et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 4, pp 892-897, issn 0931-0509, 6 p.Article